Literature DB >> 25337248

Prognostic and predictive values of SPP1, PAI and caveolin-1 in patients with oral squamous cell carcinoma.

Cong-Fa Huang1, Guang-Tao Yu1, Wei-Ming Wang1, Bing Liu2, Zhi-Jun Sun2.   

Abstract

SPP1, PAI and caveolin-1 are known to be closely associated with tumor progression in several kinds of human tumors. This study aimed to investigate the expression of SPP1, PAI and caveolin-1 in oral squamous cell carcinoma (OSCC), and to evaluate their association with the prognosis in oral carcinoma. Immunohistochemical staining was used to examine the expression of SPP1, PAI and caveolin-1 in 17 normal oral mucosa, 6 oral epithelial dysplasia and 43 OSCC specimens by tissue microarrays. High expression of SPP1, PAI and caveolin-1 was found in OSCC patients, and SPP1 and PAI expression were significantly higher in OSCC than in normal oral mucosa. No significant correlations were found between SPP1, PAI and caveolin-1 expression and clinicopathological factors. Expression of SPP1, PAI and caveolin-1 was also not associated with overall survival. Moreover, SPP1 was closely correlated with PAI, caveolin-1 and Keap1, and PAI had significant correlations with caveolin-1, Keap1 and Nrf2, and caveolin-1 was associated with Keap1 by using the Pearson correlation coefficient test. Our findings suggest that overexpressed SPP1, PAI and caveolin-1 were linked to carcinogenesis and progression, and thus they may serve as potential prognostic factors in OSCC.

Entities:  

Keywords:  PAI; SPP1; caveolin-1; oral squamous cell carcinoma; prognosis

Mesh:

Substances:

Year:  2014        PMID: 25337248      PMCID: PMC4203219     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

1.  NRF2 deficiency reduces life span of mice administered thoracic irradiation.

Authors:  Elizabeth L Travis; Girish Rachakonda; Xinhui Zhou; Katrina Korhonen; Konjeti R Sekhar; Swati Biswas; Michael L Freeman
Journal:  Free Radic Biol Med       Date:  2011-06-12       Impact factor: 7.376

Review 2.  Osteopontin: role in cell signaling and cancer progression.

Authors:  Hema Rangaswami; Anuradha Bulbule; Gopal C Kundu
Journal:  Trends Cell Biol       Date:  2006-01-10       Impact factor: 20.808

Review 3.  The plasminogen activation system in tumor growth, invasion, and metastasis.

Authors:  P A Andreasen; R Egelund; H H Petersen
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

4.  Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial.

Authors:  Annette M Lim; Danny Rischin; Richard Fisher; Hongbin Cao; Kathleen Kwok; Daniel Truong; Grant A McArthur; Richard J Young; Amato Giaccia; Lester Peters; Quynh-Thu Le
Journal:  Clin Cancer Res       Date:  2011-11-17       Impact factor: 12.531

5.  Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells.

Authors:  Dah-Yuu Lu; Wei-Lan Yeh; Ssu-Ming Huang; Chih-Hsin Tang; Hsiao-Yun Lin; Shao-Jiun Chou
Journal:  Neuro Oncol       Date:  2012-10-16       Impact factor: 12.300

6.  Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.

Authors:  Xiao-Jun Wang; Zheng Sun; Nicole F Villeneuve; Shirley Zhang; Fei Zhao; Yanjie Li; Weimin Chen; Xiaofang Yi; Wenxin Zheng; Georg T Wondrak; Pak Kin Wong; Donna D Zhang
Journal:  Carcinogenesis       Date:  2008-04-15       Impact factor: 4.944

Review 7.  Osteopontin as a target for cancer therapy.

Authors:  Nicholas I F Johnston; Vignesh Kumar Gunasekharan; Amod Ravindranath; Ciara O'Connell; Patrick G Johnston; Mohamed K El-Tanani
Journal:  Front Biosci       Date:  2008-05-01

8.  Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance.

Authors:  Wei Zhang; Dan Ling; Jie Tan; Jieqing Zhang; Li Li
Journal:  Oncol Rep       Date:  2012-11-20       Impact factor: 3.906

9.  PAI-1: An Integrator of Cell Signaling and Migration.

Authors:  Ralf-Peter Czekay; Cynthia E Wilkins-Port; Stephen P Higgins; Jennifer Freytag; Jessica M Overstreet; R Matthew Klein; Craig E Higgins; Rohan Samarakoon; Paul J Higgins
Journal:  Int J Cell Biol       Date:  2011-08-03

10.  Expression of deleted in liver cancer 1 and plasminogen activator inhibitor 1 protein in ovarian carcinoma and their clinical significance.

Authors:  Fang Ren; Huirong Shi; Gong Zhang; Ruitao Zhang
Journal:  J Exp Clin Cancer Res       Date:  2013-08-30
View more
  13 in total

1.  Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.

Authors:  Qiang Wang; Xiaoying Wang; Xiufen Tian; Ronghua Tang; Xin Xu
Journal:  J Mol Histol       Date:  2016-01-12       Impact factor: 2.611

2.  Expression and significance of caveolin-1 in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Hao Cheng; Yiming Pan; Yongzhong Yao; Zhanghua Zhu; Jun Chen; Xitai Sun; Yudong Qiu; Yitao Ding
Journal:  Exp Ther Med       Date:  2017-08-25       Impact factor: 2.447

3.  Expression of Stromal Caveolin- 1 May Be a Predictor for Aggressive Behaviour of Breast Cancer.

Authors:  Nuket Eliyatkin; Safiye Aktas; Gulden Diniz; Halil Hakan Ozgur; Zubeyde Yildirim Ekin; Ali Kupelioglu
Journal:  Pathol Oncol Res       Date:  2017-02-24       Impact factor: 3.201

4.  Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.

Authors:  Miguel Angel Pavón; Irene Arroyo-Solera; Marta Téllez-Gabriel; Xavier León; David Virós; Montserrat López; Alberto Gallardo; Maria Virtudes Céspedes; Isolda Casanova; Antonio López-Pousa; Maria Antonia Mangues; Miquel Quer; Agustí Barnadas; Ramón Mangues
Journal:  Oncotarget       Date:  2015-10-06

Review 5.  The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma.

Authors:  Pin Fu; Fuchun Chen; Qi Pan; Xianda Zhao; Chen Zhao; William Chi-Shing Cho; Honglei Chen
Journal:  Onco Targets Ther       Date:  2017-02-14       Impact factor: 4.147

6.  Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.

Authors:  Jingyuan Li; Xingyuan Liu; Zan Cui; Guanying Han
Journal:  Med Sci Monit       Date:  2020-06-24

7.  Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.

Authors:  Yujie Shen; Jinhui Liu; Liqing Zhang; Shikun Dong; Jiacheng Zhang; Yaqin Liu; Han Zhou; Weida Dong
Journal:  Biomed Res Int       Date:  2019-08-07       Impact factor: 3.411

8.  Identification of methylated-differentially expressed genes and pathways in esophageal squamous cell carcinoma.

Authors:  Liang Sang; Zhanwu Yu; Ang Wang; Hao Li; Xiantong Dai; Liping Sun; Hongxu Liu; Yuan Yuan
Journal:  Pathol Res Pract       Date:  2020-06-10       Impact factor: 3.250

Review 9.  uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.

Authors:  Miguel Angel Pavón; Irene Arroyo-Solera; Maria Virtudes Céspedes; Isolda Casanova; Xavier León; Ramón Mangues
Journal:  Oncotarget       Date:  2016-08-30

Review 10.  Genetic Susceptibility and Protein Expression of Extracellular Matrix Turnover-Related Genes in Oral Submucous Fibrosis.

Authors:  Ru-Hsiu Cheng; Yi-Ping Wang; Julia Yu-Fong Chang; Yu-Hwa Pan; Mei-Chi Chang; Jiiang-Huei Jeng
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.